Skip to main content
Have a personal or library account? Click to login
IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients Cover

IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients

Endocrine Regulations
Volume 57 (2023): Issue 1 (January 2023)
By: Emil Fraenkel and  Ivica Lazurova  
Open Access
|May 2023
Authors

Authors

Emil Fraenkel

emil.fraenkel@hotmail.com

1st Department of Internal Medicine, P.J. Safarik University, Kosice, Slovakia

Ivica Lazurova

1st Department of Internal Medicine, P.J. Safarik University, Kosice, Slovakia
DOI: https://doi.org/10.2478/enr-2023-0009 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 69 - 79
Published on: May 15, 2023
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
IGF-1,
IGFBP3,
insulin resistance,
liver steatosis
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2023 Emil Fraenkel, Ivica Lazurova, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 57 (2023): Issue 1 (January 2023)
Previous article
Next article